Business Sep 27, 2018
As China builds biotech sector, cash floods U.S. startups
by Robin Respaut and Julie Zhu
For three whirlwind days in June, U.S. scientist Zhi Hong went shopping at the Boston Bio Conference to find drugs to fill the pipeline of his 2-week-old drug company. Crammed in tight, four-person booths that executives use for private conversations, the former GlaxoSmithKline PLC executive ...